or
Looking to list your PhD opportunities? Log in here.
Background
The epithelial tissues of our bodies use physical barriers and innate defences to fight viral infection. When infections establish, tissues can call on the immune system for assistance, but epithelia have evolved sophisticated systems to coordinate the tissue in detection, encapsulation and finally apical extrusion of infected cells.
BK polyomavirus (BKPyV) is a ubiquitous childhood infection that persists, dormant in the kidney throughout adult life and can reactivate with infected cells being extruded into the urine periodically.
BKPyV reactivation under immunosuppression is responsible for one third of kidney transplant failures and a three-fold greater risk of bladder cancer in kidney transplant recipients. We recently published evidence suggesting BKPyV may be an important risk factor for bladder cancer in the ageing general population (Oncogene 2022;41:2139–2151). In ageing or immunosuppressed patients, sub-optimal immune responses make enhancing innate epithelial clearance of viral infection an attractive approach.
Objectives
Novelty
A critical part of the urinary tract response to infection is epithelial extrusion of infected “decoy” cells by the renal epithelium and urothelium, but there have been no models of this phenomenon until now. We have noted cells from different donors are highly variable in how rapidly they sense and extrude infections, suggesting potential for improvement in at-risk populations.
Experimental Approach
Our research employs two models of the normal human bladder epithelium (“urothelium”):
These models recreate the mitotically-quiescent and barrier-forming human tissue and show cells coordinating their behaviour to extrude their BKPyV-infected neighbours.
The lab has already generated RNA-sequencing data of BKPyV-infected urothelium at multiple timepoints which provides a number of hypothetical pathways involved in extrusion for the studentship to follow-up. State-of-the-art imaging approaches available in our Bioscience Technology Facility will be used to capture the process in action.
This PhD seeks new approaches to BKPyV-specific antiviral therapy driven by greater knowledge of disease-relevant urinary tract biology. Based on the data developed during this studentship we propose to test existing (and/or develop new) pharmacological modulators of the BKPyV-infection biology we observe for future use in disease prevention.
The York Biomedical Research Institute at the University of York is committed to recruiting extraordinary future scientists regardless of age, ethnicity, gender, gender identity, disability, sexual orientation, religion/belief, marital status, pregnancy and maternity, or career pathway to date. We understand that commitment and excellence can be shown in many ways and have built our recruitment process to reflect this. We welcome applicants from all backgrounds, particularly those underrepresented in science, who have curiosity, creativity and a drive to learn new skills.
The university will respond to you directly. You will have a FindAPhD account to view your sent enquiries and receive email alerts with new PhD opportunities and guidance to help you choose the right programme.
Log in to save time sending your enquiry and view previously sent enquiries
The information you submit to University of York will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
Based on your current searches we recommend the following search filters.
Check out our other PhDs in York, United Kingdom
Start a New search with our database of over 4,000 PhDs
Based on your current search criteria we thought you might be interested in these.
Understanding how electrical communication can regulate metabolic cycles in bacteria biofilms
University of Reading
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
University of Greenwich
How to build and maintain a 3-dimensional polarised epithelial sheet
University of Nottingham